Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.39 |
| ▸ | RAPGEF4 | Q8WZA2 | 3/20 | 0.35 |
| ▸ | MIF | P14174 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24390818 | 0.85 | RAPGEF4 (0.33) | GABRA1GABRB2RAPGEF4 | |
| SCHEMBL1547925 | 0.83 | MIF (0.41) | GABRA1GABRB2MIFALDH1A1LMNA | |
| SCHEMBL11414739 | 0.82 | GABRA1 (0.32) | GABRA1GABRB2 | |
| SCHEMBL11429392 | 0.82 | SMN1; SMN2 (0.41) | GABRA1GABRB2ALDH1A1 | |
| SCHEMBL11429373 | 0.82 | GABRA1 (0.52) | GABRA1GABRB2ALDH1A1LMNA | |
| SCHEMBL1457241 | 0.81 | GABRA1 (0.36) | GABRA1GABRB2MIF | |
| SCHEMBL8957812 | 0.81 | GABRA1 (0.36) | GABRA1GABRB2MIFALDH1A1 | |
| SCHEMBL14102097 | 0.81 | MEN1 (0.47) | GABRA1GABRB2MIFALDH1A1GAA | |
| SCHEMBL961129 | 0.79 | RAPGEF4 (0.38) | RAPGEF4ALDH1A1LMNAKDM4EGAA | |
| SCHEMBL26941830 | 0.79 | FFAR1 (0.31) | GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12402638-B2 | Materials and methods for extending shelf-life of foods | JP LABORATORIES, INC. (US) | 2025-09-02 | — | — | US | claimed |
| US-20250194617-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-06-19 | — | — | US | claimed |
| US-20250169514-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-05-29 | — | — | US | claimed |
| US-12232516-B2 | Materials and methods for extending shelf-life of foods | JP LABORATORIES, INC. (US) | 2025-02-25 | — | — | US | claimed |
| US-12193465-B2 | Materials and methods for extending shelf-life of foods | JP LABORATORIES, INC. (US) | 2025-01-14 | — | — | US | claimed |
| US-20230380457-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2023-11-30 | — | — | US | claimed |
| EP-4280882-A2 | MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS | JP LABORATORIES, INC. (US) | 2023-11-29 | — | — | EP | claimed |
| US-20230363426-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2023-11-16 | — | — | US | claimed |
| CN-116916755-A | Materials and methods for extending the shelf life of food products | JP实验室公司 | 2023-10-20 | — | — | CN | claimed |
| US-20220264914-A1 | MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS | JP LABORATORIES, INC. | 2022-08-25 | — | — | US | claimed |
| US-20220225647-A1 | MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS | JP LABORATORIES, INC. | 2022-07-21 | — | — | US | claimed |
| US-20220225646-A1 | MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS | JP LABORATORIES, INC. | 2022-07-21 | — | — | US | claimed |
| EP-3221309-B1 | NOVEL BENZIMIDAZOLE BASED EGFR INHIBITORS | COUNCIL SCIENT IND RES (IN) | 2019-11-13 | — | — | EP | claimed |
| EP-3253750-B1 | NOVEL FLAVONE BASED EGFR INHIBITORS AND PROCESS FOR PREPARATION THEREOF | COUNCIL SCIENT IND RES (IN) | 2019-04-10 | — | — | EP | claimed |
| US-10221165-B2 | Flavone based EGFR inhibitors and process for preparation thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2019-03-05 | — | — | US | claimed |
| US-20180016268-A1 | Novel Flavone Based EGFR Inhibitors and Process for Preparation Thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2018-01-18 | — | — | US | claimed |
| US-9862712-B2 | Benzimidazole based EGFR inhibitors | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2018-01-09 | — | — | US | claimed |
| EP-3221309-A1 | NOVEL BENZIMIDAZOLE BASED EGFR INHIBITORS | Council of Scientific and Industrial Research (IN) | 2017-09-27 | — | — | EP | claimed |
| US-20170267671-A1 | NOVEL BENZIMIDAZOLE BASED EGFR INHIBITORS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2017-09-21 | — | — | US | claimed |
| WO-2016079763-A1 | NOVEL BENZIMIDAZOLE BASED EGFR INHIBITORS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-05-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170267671-A1 | NOVEL BENZIMIDAZOLE BASED EGFR INHIBITORS | EGFR, ERBB4, ERBB2 | GABRA1 1933/4885GABRB2 1253/4885RAPGEF4 3046/4885 |
| US-20180016268-A1 | Novel Flavone Based EGFR Inhibitors and Process for Preparation Thereof | EGFR, ERBB2, ABL1 | GABRA1 3129/4885GABRB2 3415/4885RAPGEF4 1358/4885 |
| US-10221165-B2 | Flavone based EGFR inhibitors and process for preparation thereof | EGFR, ERBB2, ABL1 | GABRA1 3100/4885GABRB2 3429/4885RAPGEF4 1539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.